S. Typhimurium strategies to resist killing by cationic antimicrobial peptides  by Matamouros, Susana & Miller, Samuel I.
Biochimica et Biophysica Acta 1848 (2015) 3021–3025
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemReviewS. Typhimurium strategies to resist killing by cationic
antimicrobial peptides☆Susana Matamouros a, Samuel I. Miller a,b,c,⁎
a Departments of Microbiology, University of Washington, Seattle, WA 98195, USA
b Departments of Genome Sciences, University of Washington, Seattle, WA 98195, USA
c Department of Medicine, University of Washington, Seattle, WA 98195, USAAbbreviations: AMP, antimicrobial peptides; CAMP, c
LPS, lipopolysaccharide; CRAMP, cathelicidin-related anti-
☆ This article is part of a Special Issue entitled: Bacter
Peptides.
⁎ Corresponding author at: Department of Microbiolo
Seattle, WA 98195, USA.
E-mail address:millersi@uw.edu (S.I. Miller).
http://dx.doi.org/10.1016/j.bbamem.2015.01.013
0005-2736/© 2015 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 5 December 2014
Received in revised form 18 January 2015
Accepted 21 January 2015
Available online 30 January 2015
Keywords:
Salmonella Typhimurium
Resistance to cationic antimicrobial peptide
Polymyxin
Outer-membrane remodeling
Lipid A modiﬁcationS. Typhimurium is a broad host range Gram-negative pathogen that must evade killing by host innate immune
systems to colonize, replicate, cause disease, and be transmitted to other hosts. A major pathogenic strategy of
Salmonellae is entrance, survival, and replication within eukaryotic cell phagocytic vacuoles. These phagocytic
vacuoles and gastrointestinal mucosal surfaces contain multiple cationic antimicrobial peptides (CAMPs)
which control invading bacteria. S. Typhimurium possesses several key mechanisms to resist killing by CAMPs
which involve sensing CAMPs and membrane damage to activate signaling cascades that result in remodeling
of the bacterial envelope to reduce its overall negative charge with an increase in hydrophobicity to decrease
binding and effectiveness of CAMPs. Moreover Salmonellae have additional mechanisms to resist killing by
CAMPs including an outer membrane protease which targets cationic peptides at the surface, and speciﬁc efﬂux
pumps which protect the inner membrane from damage. This article is part of a Special Issue entitled: Bacterial
Resistance to Antimicrobial Peptides.
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Antimicrobial peptides (AMPs) are ubiquitously produced as part of
themammalian innate immune systems andmake up the entire immuneationic antimicrobial peptides;
microbial peptide
ial Resistance to Antimicrobial
gy, University of Washington,system of insects andmany non-vertebrate animals. They are structurally
diverse small amphipathic peptides in which a cationic surface and a
hydrophobic surface facilitate interaction with biological membranes
[1–4]. Unlike eukaryotic cells, the bacterial outer layer net surface charge
is anionic [2]. Gram-negative bacteria have negatively-charged lipopoly-
saccharides (LPS) as the major constituent of the outer-leaﬂet of their
outer-membranes and Gram-positive bacteria have acidic polysaccha-
rides (teichoic and teichuronic acids) decorating their surface. Conse-
quently most AMPs with activity against bacteria are cationic which
allows binding to the negatively charged bacterial surface [2–4].
Thus, surface remodeling aimed at decreasing the negative charge
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as a ﬁrst line of defense in bacterial resistance to antimicrobial peptides.
Remodeling of the bacterial surface has been extensively studied in
the Gram-negative pathogenic bacterium Salmonella enterica serovar
Typhimurium. Salmonella is able to reduce recognition by the host innate
immune system and binding of CAMPs to its surface by speciﬁcmodiﬁca-
tion of its outer membrane components. Several strategies have been
identiﬁed in Salmonellae and other Gram-negative bacteria that result in
the modiﬁcation of the LPS structure and properties as well as sequester-
ing, efﬂux and proteolytic degradation of AMPs.
2. Regulatory systems
Salmonella possesses several regulatory systems that control modiﬁ-
cations necessary for AMP resistance. The regulation of the proteins
involved in these processes is complex and involves several regulatory
proteins such as the alternative sigma factor, RpoE [5] and several
two-component systems: PhoPQ, PmrAB and RcsABCDF (Fig. 1) [6–8].
S. Typhimurium and other Gram-negative bacteria regulate most
changes to the outer-membrane through the two-component system
PhoPQ [9–11]. PhoQ is an inner-membrane histidine kinase that is acti-
vated once Salmonella is inside host cells and responds to low pH and
the presence of AMPs [7,12–14]. The presence of these signals leads
to the phosphorylation of the cytoplasmic response regulator PhoP
(Fig. 1). PhoQ periplasmic domain contains a negatively charged surface
(acidic patch) facing themembrane that is tethered to the anionic phos-
pholipid head-groups of the inner-membrane by the presence of metal
ions such as Ca2+ and Mg2+ keeping it in a repressed state [15]. Direct
interaction of the PhoQ periplasmic domain acidic patch with the posi-
tively charged surface of CAMPs disrupts themetal bridges and induces
conformational changes in PhoQ that lead to PhoQ autophosphorylation
and subsequent transfer of the phosphate group to PhoP (Fig. 1) [13].
Once phosphorylated, PhoP controls the expression of several genes
involved in resistance to AMPs and intracellular survival and hence
virulence.
PhoPQ also regulates the transcription of another two-component
system, PmrAB that is necessary for Salmonella resistance to AMPs
[6,16]. Upon activation PhoP induced synthesis of PmrD preventsFig. 1.Regulatory systems that control severalmodiﬁcations essential for Salmonella resistance t
is able to directly bind CAMPs via its periplasmic domainwhich results in activation of the PhoPQ
CAMPs, among which is the outer-membrane protease PgtE. Activation of the Rcs phosphorela
caused by CAMPs. The concerted activation of these regulons results in increased resistance tothe dephosphorylation of PmrA keeping it in an activating state
(Fig. 1) [17,18]. Activation of PmrAB can also occur in the presence of
ferric iron or low pH [19,20]. PmrA directly controls the expression of
several genes involved in LPS modiﬁcations that are absolutely necessary
for resistance to Polymyxin B and other CAMPs.
The Rcs regulatory system involves several regulatory proteins and a
multiple-step phosphotransfer cascade. It is composed of two inner-
membrane sensors, the RcsC hybrid kinase and the RcsD histidine
phosphotransfer protein, an outermembrane inner leaﬂet and periplas-
mic lipoprotein RcsF and two cytoplasmic regulatory proteins, RcsA and
RcsB (Fig. 1) [21,22]. RcsF is essential for the activation of this system in
the presence of CAMP, likely through speciﬁc disorder of the outer
membrane and alteration in the localization or conformation of RcsF
[8]. The Rcs system controls the expression of the capsular polysaccha-
ride genes as well as other genes necessary for Salmonella resistance
to antimicrobial peptides and persistence in mice [23,24].
3. Regulation of O-antigen length
The outer-leaﬂet of the outer-membrane of Gram-negative bacteria
is mainly composed of LPS. LPS is a complex amphiphilic molecule com-
posed of three distinct domains: the hypervariable and highly immuno-
genic O-region formed by repeating oligosaccharide subunits; a short
core oligosaccharide region usually common to all members of a bacte-
rial genus and; amembrane anchoring hydrophobic lipid composed of a
phosphorylated glucosamine disaccharide that in enteric bacteria most
often has 6 attached fatty acids, termed lipid A. Since LPS is the
major component of the outer leaﬂet of the outer membrane of
Gram-negative bacteria, it is therefore a ﬁrst barrier in the defense
against external toxins such as AMPs. Being the outermost portion of
the LPS molecule and bacterial cellular surface, the O-antigen serves
as a protective barrier from CAMPs and other membrane active com-
pounds. It hides the negatively charged phosphate groups of the core
and lipid A inhibiting the electrostatic attraction between the CAMPs
and these two domains of the LPSmolecule. S. Typhimurium can produce
short LPS species with the O-antigen domain containing between 1 and
15 oligosaccharide repeat units, long LPS species that have 16 to 35 O-
antigen repeat units [25], or very long LPS chains canhaveover 100 repeatoCAMPs. Uponexposure to CAMPs there is disruption of the outermembrane barrier. PhoQ
and the PmrAB operons. These operons encode several proteins essential for resistance to
y system occurs via the outer-membrane lipoprotein RcsF that senses membrane damage
CAMPs.
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species is controlled by the length regulators: PbgE2,3, WzzST and FepE,
respectively. The expression of these proteins is under the direct control
of the PmrAB regulatory system [27,28]. The presence of O-antigen has
been shown to be important to resistance to Polymyxin B since a
S. Typhimurium mutant devoid of O-antigen shows high susceptibility
to this antimicrobial peptide [29]. However, S. Typhimurium mutants
devoid of long and/or very long O-antigen species show only a mild
increase in susceptibility to Polymyxin B [27,29] and the LPS of PhoP
constitutive strains presents shorter O-antigen chains [30,31]. Together
this suggests that short O-antigen chains are sufﬁcient in providing a
barrier against Polymyxin B and possibly other antimicrobial peptides. It
is conceivable that the overall shorter length leads to a more uniform
surface, rather than a number of shorter and longer chains, which could
form a more effective barrier.
4. Reduction of the anionic character of the bacterial surface
Another strategy employed by bacteria to resist AMPs is to reduce
the negative charge of its surface. In Gram-negative this is achieved by
modiﬁcation of the anionic phosphate groups in the core and lipid A
regions of the LPS with the addition of cationic aminoarabinose and
zwitterionic phosphoethanolamine moieties (Fig. 2) [30,32,33]. The
lipid A of Salmonella is phosphorylated at the 1 and 4′ positions [34].
The addition of aminoarabinose and phosphoethanolamine at these posi-
tions is catalyzed by the PmrA-dependent ArnT (PmrK) [35,36] and EptA
(PmrC) enzymes [37], respectively. In S. Typhimurium, aminoarabinose isLipid A
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Fig. 2. S. Typhimurium LPS structure. Important modiﬁcations for resistance to CAMPs are ind
aminoarabinose and zwitterionic phosphoethanolamine moieties neutralizes the negative ch
increased membrane hydrophobicity and thickness which along with the charge neutralizationusually added to the 4′-phosphate group and the phosphoethanolamine
group added to the 1-phosphate group of lipid A, however in some
cases both positions can be modiﬁed by the same cationic group [38].
PmrA activation also inhibits the activity of LpxT, an undecaprenyl phos-
photransferase responsible for increasing the negative charge of LPS by
adding an additional phosphate at the 1-position [39–41]. The concerted
inhibition of LpxT and the addition of cationic groups to lipid A highly
contribute to S. Typhimurium resistance to Polymyxin B and other
CAMPs [37,39–42] by decreasing the negative charge of the outer
membrane and therefore electrostactic interactions with CAMPs.
5. Decrease in bacterial surface membrane ﬂuidity
In order to diminish the interaction and uptake of AMPs Salmonella
species are able to reduce the ﬂuidity of their outer membrane by
increasing its hydrophobicity. This is achieved by adding additional
palmitate to Lipid A to form hepta-acylated Lipid A. This modiﬁcation is
catalyzed by the outer-membrane enzyme PagP that catalyzes lipid A
palmitoylation (Fig. 2) [43,44]. The expression of this enzyme is under
the control of the PhoPQ two component system and its activity highly
contributes to CAMPs resistance [43,44]. Recently, we have demonstrated
that PagP can also catalyze the palmitoylation of phosphatidylglycerol on
the outer-membrane of S. Typhimurium [45]. In certain S. Typhimurium
mutants [46], possibly upon disruption of the outer-membrane barrier,
phospholipids migrate to the outer-leaﬂet of the outer-membrane to try
to keep membrane integrity providing an additional substrate for PagP.
Palmitoylation of Lipid A and phosphatidylglycerol contribute to thequose
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icated in red along with the enzyme that catalyzes the reaction. The addition of cationic
arges of the phosphate groups. Lipid A palmitoylation is catalyzed by PagP and results in
help prevent or delay CAMPs insertion in the membrane.
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brane, which are thought to decrease ﬂuidity and prevent and delay
CAMP insertion.6. Binding and eﬂux of CAMPs
Additional resistance mechanisms employed by Salmonella and other
bacteria include binding, active efﬂux, or proteolytic degradation of AMPs
before they can exert their action in their intra- or extra-cellular targets.
Two S. Typhimurium PhoPQ regulated proteins, Mig-14 and VirK are
necessary for resistance to the cathelicidin-related anti-microbial pep-
tide (CRAMP) and Polymyxin B [23,47–49]. These two adjacent genes
are transcriptionally upregulated once inside macrophages and in the
presence of AMPs [49]. Mutants in these genes are attenuated inmacro-
phage survival and long-term persistence in mice though their mecha-
nism of action or alteration of the cell envelope is unknown [48,50]. It
has been shown that the inner membrane proteins, Mig-14 and VirK
inhibit binding of CRAMP to S. Typhimurium cells and therefore it was
proposed that by binding CRAMP they prevent access of this AMP to
its cytoplasmic target [47]. Another hypothesis is that these proteins
could interact with efﬂux or degradation systems.
The only efﬂux systems identiﬁed in Salmonella for the export of
AMPs are encoded by the sap (sensitivity to antimicrobial peptides)
genes [51–53]. These genes are necessary for CAMP resistance and for
virulence in a mouse model of infection [51]. The sapABCDF operon
was shown to encode an ABC transporter that is involved in resistance
to small cationic peptides [52]while sapGand sapJ are involved in peptide
resistance and potassium transport and couldmake part of the SapABCDF
complex [53].7. Proteolytic degradation of CAMPs
In S. Typhimurium proteolytic degradation of CAMPs is accom-
plished by the outer-membrane protease PgtE [54] from the OmpT/Pla
family of outer-membrane proteases (Fig. 1). Although transcription
of PgtE was found to be PhoPQ independent its localization and or
stability within the outer-membrane is dependent upon PhoPQ activa-
tion and its activitywas found to be directed speciﬁcally to alpha-helical
peptides such as C18G and LL-37 [54]. PgtE does not confer resistance to
β-sheet AMPs which form more rigid structures stabilized by disulﬁde
bonds. Some of these AMPs such as α- and β-defensins only exist in
mammals and may have evolved as part of the mammalian defense
response to microbial invasions to overcome degradation by proteases
produced by several bacteria [55].8. Conclusion
Salmonellae are intracellular pathogens which through the course of
infection encounter a variety of innate immune CAMPs with diverse
targets and modes of action. S. Typhimurium possesses multiple strate-
gies to resist killing by CAMPs. All these processes are highly regulated
and often redundant, similar to mammalian innate immune receptors
and responses. Inducible AMP resistance is an old process in bacteria
since AMPs are produced by bacteria and may have originally evolved
before eukaryotes as a mechanism to resist polymyxins produced
by Bacillus spp. Resistance to AMPs likely facilitated the success of
Salmonellae as gastrointestinal and systemic intracellular pathogens.
Understanding these mechanisms and others involved in the inducible
response to AMPs that result in an increase in outer membrane barrier
could promote the development of new antibiotics that target this bar-
rier, improve the action of current antibiotics which are ineffective as a
result of this inducible barrier andmay lead to the identiﬁcation of new
antibiotic targets for antimicrobial development.Conﬂict of interest
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